Clinical Trials Logo

Pulmonary Function clinical trials

View clinical trials related to Pulmonary Function.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06106646 Recruiting - Asthma Clinical Trials

Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) Longer Term Follow Up

VCSIP
Start date: October 11, 2023
Phase:
Study type: Observational

The overall aims of this protocol are to determine whether prenatal supplementation with vitamin C to pregnant smokers can improve pulmonary function at 10 years of age in their offspring. This is an additional continuation of the Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) trial, to follow the offspring through 10 years of age. The hypothesis for this protocol is an extension of the VCSIP trial that supplemental vitamin C in pregnant smokers can significantly improve their children's airway function tests. The investigators aim to demonstrate sustained improvement in airway/pulmonary function and trajectory through 10 years of age.

NCT ID: NCT05933317 Recruiting - Pulmonary Function Clinical Trials

A Long-term Follow-up Study of Pulmonary Function Changes Using Phase-resolved Functional Lung MRI in Patients With COVID-19

Start date: January 1, 2023
Phase:
Study type: Observational

So far, the number of COVID-19 infections worldwide has exceeded 700 million. Long-term damage to the lungs is a major sequela of COVID infection. Pulmonary function testing is an important means for the evaluation of lung damage. MRI examinations with free breathing and no contrast agent can prevent patients from suffering from ionizing radiation damage caused by multiple CT examinations.

NCT ID: NCT05692258 Recruiting - Acupuncture Clinical Trials

Acupuncture as an Adjunctive Therapy for Covid-19 Omicron Randomised Controlled Trial in Patients With Moderate/Severe Pneumonia

ZCFZZLXGBDFYHZ
Start date: January 6, 2023
Phase: N/A
Study type: Interventional

At present, China is facing the first wave of COVID-19 epidemic after the liberalization. The infection rate has exceeded 50% in most areas, and even exceeded 80% in some cities. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) belongs to the beta genus of coronavirus and enters cells mainly by binding angiotensin converting enzyme 2 (ACE-2) to the spike protein on the envelope. The Omicron strain is the main epidemic strain at present. The transmission ability of Omicron strain is stronger than Delta strain, but the pathogenicity is weakened. At present, the published articles on the adjuvant treatment of COVID-19 with acupuncture are mostly theoretical discussions or case reports, and randomized controlled trials on the observation of curative effect are rare. The purpose of this study is to clarify the effectiveness of the adjuvant treatment of COVID-19 with acupuncture. Providing high-level research evidence for them.

NCT ID: NCT05494333 Recruiting - Physical Fitness Clinical Trials

Correlation Between Pulmonary Functions and Physical Fitness in Children With β-thalassemia

Start date: August 1, 2022
Phase:
Study type: Observational

The aims of this study are: 1. To determine the correlation between pulmonary functions and physical fitness in children with β-thalassemia. 2. To differentiate between different types of B-thalassemia in both pulmonary functions and physical fitness

NCT ID: NCT05483361 Recruiting - Pulmonary Function Clinical Trials

Effect Of Smart Phone Addiction On Pulmonary Function, And Functional Capacity In Children

Start date: July 1, 2022
Phase:
Study type: Observational

Statement of the problem: Are there relations between smartphone addiction, neck posture, pulmonary functions and functional capacity in children? Null hypothesis It will be assumed that: - There will be no effect of smart phone addiction on head posture, pulmonary function and functional capacity in children. - There will be no relation between smartphone addiction, head posture, pulmonary function and functional capacity in children.

NCT ID: NCT05289245 Recruiting - Pulmonary Function Clinical Trials

A National Registry on Chinese Patients With Cystic Fibrosis

Start date: April 1, 2022
Phase:
Study type: Observational [Patient Registry]

Cystic fibrosis (CF) is a rare autosomal recessive disease involving multiple organs, especially the lungs and digestive organs. It is most commonly seen in Caucasians. Only a few Chinese CF patients have been described in literature, taking into account the large population of China. The main objectives of this study are to accurately evaluate the prevalence of CF, the status of disease, the diagnosis and treatment, the quality of care, and the health related outcomes in China.

NCT ID: NCT05190497 Recruiting - Pulmonary Function Clinical Trials

Effects of IMT on Pulmonary Functions IN CASES With Inhalation Injury

Start date: November 30, 2021
Phase: N/A
Study type: Interventional

The current study aimed to investigate the effect of inspiratory muscle training (IMT) on pulmonary functions (FEV1and FVC), and respiratory muscle strength in patients with inhalation injury, which may prove to be a promising intervention helping to improve exercise tolerance, relieve dyspnea and suggests an improvement in respiratory muscle function.

NCT ID: NCT03206710 Recruiting - Asthma Clinical Trials

Vitamin C Supplementation to Pregnant Smokers: Follow-up of 2 Randomized Trials Plus Changes in DNA Methylation

VCSIP-ECHO
Start date: June 1, 2017
Phase:
Study type: Observational

In a randomized clinical trial (RCT) published in JAMA, the investigators have provided evidence that vitamin C supplementation (500 mg daily during pregnancy) ameliorates the effects of maternal smoking during pregnancy on offspring lung function and subsequent incidence of wheeze by 48% through 1 year of age. The investigators are currently completing a second RCT of vitamin C supplementation in pregnant smokers with more robust measures of pulmonary outcomes. The purpose of this ECHO application is to combine these 2 focused, interventional cohorts to allow critical longitudinal follow-up of respiratory outcomes in these children including the study of pulmonary function test (PFT) trajectories and incidence of recurrent wheeze/asthma from infancy through early adolescence in offspring of pregnant smokers randomized to vitamin C versus placebo.

NCT ID: NCT03203603 Recruiting - Asthma Clinical Trials

VCSIP Follow-up Study

VCSIPRenewal
Start date: March 27, 2017
Phase:
Study type: Observational

The overall aims of this protocol are to determine whether prenatal supplementation with vitamin C to pregnant smokers can improve pulmonary function and decrease wheeze at 5 years of age in their offspring. This is a continuation of the VCSIP trial, to follow the offspring through 5 years of age. The hypothesis for this protocol is an extension of the VCSIP trial that supplemental vitamin C in pregnant smokers can significantly improve their children's PFTs and decrease the incidence of wheeze.

NCT ID: NCT03193892 Recruiting - Pulmonary Function Clinical Trials

A National Registry on Chinese Patients With Lymphangioleiomyomatosis

Start date: January 1, 2017
Phase:
Study type: Observational [Patient Registry]

Pulmonary lymphangioleiomyomatosis (LAM), a disease characterized by diffuse cystic changes in the lung, is a rare disorder that affects almost exclusively women. The main objectives of this study are to accurately evaluate the prevalence of LAM, the status of disease, the diagnosis and treatment, the quality of care, and the health related outcomes in China.